APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer
The EMBO Journal (2012) - Comments
pubmed: 22293751  doi: 10.1038/emboj.2011.490  issn: 1460-2075  issn: 0261-4189 

Rachel Brough, Ilirjana Bajrami, Radost Vatcheva, Rachael Natrajan, Jorge S Reis-Filho, Christopher J Lord, Alan Ashworth